New England Journal of Medicine , 251 (5), 161168
While absorption rates may vary between oral and injectable forms, many prefer oral BPC-157 for its convenience, ease of use, and ability to fit into a daily supplement stack
Half-life Not established in humans no published human pharmacokinetic study exists
Enhanced tissue repair signaling in experimental models
External resources NEJM Phase 2 Trial: Triple Hormone Receptor Agonist Retatrutide for Obesity PMC Review: Retatrutide - A Game Changer in Obesity Pharmacotherapy ClinicalTrials.gov: Retatrutide TRIUMPH Clinical Trial Registry Nature Medicine: Retatrutide for Metabolic Dysfunction-Associated Steatotic Liver Disease For researchers serious about optimizing their retatrutide protocols, SeekPeptides offers the most comprehensive resource available, with evidence-based guides, personalized protocol builders, dosing calculators, and a community of thousands who have navigated these exact questions
